EECP (Enhanced External Counter pulsation) Therapy is terms that describe the noninvasive, complementary, or alternative treatment prescribed by physicians and cleared for marketing by the U.S.
FDA as a Class device for the treatment of patients with chronic stable angina that is refractory to optimal anti-anginal medic therapy and without options for revascularizations. It has also been used and shown to be effective in published clinical studies for patients suffering from the symptoms of ischemic cardiovascular and other circulatory involved diseases such as congestive heart failure, peripheral vascular disease, stroke, diabetes, renal disease, erectile dysfunction, high blood pressure, and other disease or patient conditions that may benefit from improved circulation and blood flow.